{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:30:26Z","timestamp":1792459826242,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"vor","delay-in-days":3380,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1093\/annonc\/mdq059","type":"journal-article","created":{"date-parts":[[2010,3,17]],"date-time":"2010-03-17T00:26:12Z","timestamp":1268785572000},"page":"1898-1904","source":"Crossref","is-referenced-by-count":20,"title":["A 3-day short course of palifermin before HDT reduces toxicity and need for supportive care after autologous blood stem-cell transplantation in patients with multiple myeloma"],"prefix":"10.1016","volume":"21","author":[{"given":"G.","family":"Kobbe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Bruns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Czibere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Warnecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Hieronimus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Safaian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kondakci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Saure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Germing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Fenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdq059_bb0010","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199607113350204","article-title":"A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome","volume":"335","author":"Attal","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdq059_bb0015","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1056\/NEJMoa022340","article-title":"High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma","volume":"348","author":"Child","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdq059_bb0020","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s005209900095","article-title":"Patient reports of complications of bone marrow transplantation","volume":"8","author":"Bellm","year":"2000","journal-title":"Support Care Cancer"},{"key":"10.1093\/annonc\/mdq059_bb0025","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1200\/JCO.1999.17.8.2446","article-title":"Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplants","volume":"17","author":"Rapoport","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq059_bb0030","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1365-2141.2005.05641.x","article-title":"High-dose idarubicin, cyclophosphamide and melphalan as conditioning for autologous stem cell transplantation increases treatment-related mortality in patients with multiple myeloma: results of a randomised study","volume":"130","author":"Fenk","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1093\/annonc\/mdq059_bb0035","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1200\/JCO.2001.19.8.2201","article-title":"Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation","volume":"19","author":"Sonis","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq059_bb0040","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/cncr.20162","article-title":"Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients","volume":"100","author":"Sonis","year":"2004","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdq059_bb0045","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1056\/NEJMoa040125","article-title":"Palifermin for oral mucositis after intensive therapy for hematologic cancers","volume":"351","author":"Spielberger","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdq059_bb0050","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/sj.bmt.1705471","article-title":"Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model","volume":"38","author":"Grazziutti","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdq059_bb0055","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1200\/JCO.2007.13.6028","article-title":"Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy\u2014European Blood and Marrow Transplantation Mucositis Advisory Group","volume":"26","author":"Blijlevens","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq059_bb0060","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1182\/blood-2006-04-017780","article-title":"Phase 1\/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT)","volume":"108","author":"Blazar","year":"2006","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdq059_bb0065","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.bbmt.2008.06.013","article-title":"Long-term follow-up of a phase I\/II randomized, placebo-controlled trial of palifermin to prevent graft-versus-host disease (GVHD) after related donor allogeneic hematopoietic cell transplantation (HCT)","volume":"14","author":"Levine","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1093\/annonc\/mdq059_bb0070","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1093\/annonc\/mdn179","article-title":"Use of palifermin for the prevention of high-dose methotrexate-induced oral mucositis","volume":"19","author":"Schmidt","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdq059_bb0075","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1200\/JCO.2005.04.1152","article-title":"Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy","volume":"24","author":"Rosen","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq059_bb0080","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.exphem.2006.06.002","article-title":"Sustained G-CSF plasma levels following administration of pegfilgrastim fasten neutrophil reconstitution after high-dose chemotherapy and autologous blood stem cell transplantation in patients with multiple myeloma","volume":"34","author":"Fenk","year":"2006","journal-title":"Exp Hematol"},{"key":"10.1093\/annonc\/mdq059_bb0085","series-title":"WHO Handbook for Reporting Results of Cancer Treatment","author":"World Health Organization","year":"1979"},{"key":"10.1093\/annonc\/mdq059_bb0090","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/sj.bmt.1705956","article-title":"The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products","volume":"41","author":"Gratwohl","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdq059_bb0095","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1056\/NEJMoa0801479","article-title":"Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma","volume":"359","author":"San Miguel","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdq059_bb0100","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1182\/blood-2008-04-149427","article-title":"Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial","volume":"112","author":"Palumbo","year":"2008","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdq059_bb0105","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0140-6736(07)61537-2","article-title":"Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial","volume":"370","author":"Facon","year":"2007","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdq059_bb0110","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2275::AID-CNCR25>3.0.CO;2-Q","article-title":"The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies","volume":"82","author":"Ruescher","year":"1998","journal-title":"Cancer"},{"issue":"2","key":"10.1093\/annonc\/mdq059_bb0115","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/bmt.2008.299","article-title":"The prospective oral mucositis audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT","volume":"43","author":"McCann","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdq059_bb0120","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/sj.bmt.1705384","article-title":"A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation","volume":"37","author":"Lilleby","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdq059_bb0125","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s00520-004-0726-y","article-title":"Oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients","volume":"13","author":"Aisa","year":"2005","journal-title":"Support Care Cancer"},{"key":"10.1093\/annonc\/mdq059_bb0130","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/cncr.22484","article-title":"Updated clinical practice guidelines for the prevention and treatment of mucositis","volume":"109","author":"Keefe","year":"2007","journal-title":"Cancer"},{"issue":"Suppl 1","key":"10.1093\/annonc\/mdq059_bb0135","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.6004\/jnccn.2008.2001","article-title":"NCCN Task Force Report. Prevention and management of mucositis in cancer care","volume":"6","author":"Bensinger","year":"2008","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1093\/annonc\/mdq059_bb0140","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/annonc\/mdl332","article-title":"Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis","volume":"18","author":"Blijlevens","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdq059_bb0145","first-page":"3","article-title":"Efficacy of recombinant human keratinocyte growth factor in reducing mucositis in patients with hematologic malignancies undergoing autologous peripheral plod progenitor transplantation after radiation-based conditioning\u2014results of a phase II study","volume":"30","author":"Spielberger","year":"2001","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1093\/annonc\/mdq059_bb0150","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.ejca.2005.04.030","article-title":"Assessment of oral mucositis in clinical trials: impact of training on evaluators in a multi-centre trial","volume":"41","author":"Stokman","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdq059_bb0155","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1200\/JCO.2003.10.079","article-title":"Randomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy: potential role as mucosal protectant","volume":"21","author":"Meropol","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq059_bb0160","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/sj.bmt.1704948","article-title":"Melphalan 200 mg\/m2 with blood stem cell support as first-line myeloma therapy: impact of glomerular filtration rate on engraftment, transplantation-related toxicity and survival","volume":"35","author":"Carlson","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdq059_bb0165","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1046\/j.1365-2141.2001.03033.x","article-title":"Results of autologous stem cell transplant in multiple myeloma patients with renal failure","volume":"114","author":"Badros","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1093\/annonc\/mdq059_bb0170","first-page":"1555","article-title":"The outcome of autologous stem cell transplantation in patients with plasma cell disorders and dialysis-dependent renal failure","volume":"91","author":"Raab","year":"2006","journal-title":"Haematologica"},{"key":"10.1093\/annonc\/mdq059_bb0175","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2141.2006.06191.x","article-title":"The clinical outcome and toxicity of high-dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British Society of Blood and Marrow Transplantation study","volume":"134","author":"Bird","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1093\/annonc\/mdq059_bb0180","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1177\/0091270006292705","article-title":"Effect of renal function on the pharmacokinetics of palifermin","volume":"46","author":"Gillespie","year":"2006","journal-title":"J Clin Pharmacol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419400707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419400707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/21\/9\/1898\/341256\/mdq059.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T09:38:44Z","timestamp":1624700324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419400707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0923753419400707"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdq059","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}